SCHEMBL6848120

SCHEMBL6848120

Cc1ccc(NC(=S)N/N=C/c2ccc(C(F)(F)F)cc2)c(C)c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX12 P18054 2/20 0.60
▸ GAA P10253 2/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ HTT P42858 2/20 0.58
▸ MAPT P10636 1/20 0.58
▸ LMNA P02545 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ RRM1 P23921 3/20 0.53
▸ RRM2 P31350 3/20 0.53
▸ RRM2B Q7LG56 3/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ XBP1 P17861 1/20 0.50
▸ NPC1 O15118 2/20 0.47
▸ ATM Q13315 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ PTPN1 P18031 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5180298 1.00 ALOX12 (0.60) ALOX12GAANPSR1HTTMAPT
SCHEMBL5181864 0.84 ALOX12 (0.68) ALOX12GAANPSR1HTTMAPT
SCHEMBL5181869 0.84 ALOX12 (0.68) ALOX12GAANPSR1HTTMAPT
SCHEMBL6848013 0.84 MAPT (0.61) ALOX12GAANPSR1HTTMAPT
SCHEMBL5180461 0.84 MAPT (0.61) ALOX12GAANPSR1HTTMAPT
SCHEMBL5181464 0.84 ALOX12 (0.67) ALOX12GAANPSR1HTTMAPT
SCHEMBL5181467 0.84 ALOX12 (0.67) ALOX12GAANPSR1HTTMAPT
SCHEMBL5179588 0.82 GAA (0.61) ALOX12GAANPSR1HTTMAPT
SCHEMBL5181488 0.82 ALOX12 (0.70) ALOX12GAANPSR1HTTMAPT
SCHEMBL5179591 0.82 GAA (0.61) ALOX12GAANPSR1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6794400-B2 USE AS ANTICANCER AGENTS AND IN OTHER CONDITIONS INVOLVING ABNORMAL CELL PROLIFERATION SUCH AS RHEUMATOID ARTHRITIS CYTOVIA, INC. 2004-09-21 — — US disclosed
US-20030045581-A1 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof DISCOVER GROWTH FUND, LLC (VI) 2003-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045581-A1 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof CASP1, CASP3, CASP4 ALOX12 3136/4885GAA 2524/4885NPSR1 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback